0001209191-21-036315.txt : 20210527
0001209191-21-036315.hdr.sgml : 20210527
20210527180617
ACCESSION NUMBER: 0001209191-21-036315
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210525
FILED AS OF DATE: 20210527
DATE AS OF CHANGE: 20210527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chen Jinzhu PhD
CENTRAL INDEX KEY: 0001864373
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 21974753
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-05-25
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001864373
Chen Jinzhu PhD
12230 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
1
0
0
0
Stock Options
5.14
2021-05-25
4
A
0
50000
0.00
A
2031-05-25
Common Stock
50000
50000
D
One thirty-sixth of the shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the date of grant, such that the shares subject to the option shall be fully vested on the three-year anniversary of the date of grant, subject to the Reporting Person's continued service on the Board through each such vesting date.
/s/Chase C. Leavitt, Attorney-in-fact
2021-05-27